Zepbound 15 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FTWB5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,439
Award facts
- Contract value 100% obligated
- $11,438.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,438.70 to DMS Pharmaceutical Group Inc. for Zepbound 15 mg/0.5 ml pen injections on August 7, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order was issued without a set-aside designation and will be performed in Conshohocken, Pennsylvania. Zepbound is a semaglutide-based medication used for weight management, and this delivery order represents a specific fulfillment under DMS Pharmaceutical Group's broader pharmaceutical supply agreement with the Defense Logistics Agency.
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, holds a significant single-award Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 through November 2026 under the SPE2DB program. This delivery order is issued pursuant to that master contract, which enables the agency to procure a comprehensive range of pharmaceutical products, including prescription medications, biologics, and medical consumables to support Department of Defense healthcare facilities worldwide. The company has demonstrated consistent success in federal pharmaceutical procurement and serves as a critical supplier in the federal pharmaceutical supply chain for military health systems.
Quick answers
Who was awarded contract SPE2DB25FTWB5?
SPE2DB25FTWB5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 7, 2025.
How much is contract SPE2DB25FTWB5 worth?
The government has obligated $11,439 on SPE2DB25FTWB5.
Is contract SPE2DB25FTWB5 an order under another contract?
Yes. SPE2DB25FTWB5 is a delivery order under SPE2DB20D6037, an indefinite delivery contract.
Was contract SPE2DB25FTWB5 competed?
The extent of competition for SPE2DB25FTWB5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award